Description
Therapeutic Segment: Anti-Diabetic
Generic Name: Pioglitazone HCl + Metformin HCl
Indication:For the improvement of glycemic control in patients with Type 2 Diabetes Mellitus (NIDDM) inadequately controlled by diet and exercise. As dual oral therapy in adult patients with metformin, or sulfonylurea in insufficient glycemic control.
Additional information
| brand | Getz Pharma |
|---|
